Solta Medical Inc

Plummeting stock prices for biotechnology companies and declining valuations across the industry were common topics at the BIO International Convention 13-16 June in San Diego. However, attendees also

Karolinska Development AB has appointed current deputy CEO and chief investment officer Viktor Drvota CEO, following the resignation of current CEO, Jim Van heusden . Drvota’s appointment will

Valeant Pharmaceuticals International Inc. is turning its back on CEO J. Michael Pearson, the man who built Valeant into a Wall Street darling through a strategy of acquisitions, cost cuts and price

IN VITRO DIAGNOSTICS Alliances Abbott Laboratories Inc. Idera Pharmaceuticals Inc. Idera Pharmaceuticals Inc. (toll-like receptor (TLR) antagonists for autoimmune diseases and B-cell lymphomas) si